| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |